Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way.

@article{Yue2013RiccardinDA,
  title={Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way.},
  author={Bin Yue and Yu-sheng Zhang and Huihua Xu and Cui-rong Zhao and Yuan-yuan Li and Yizhuo Qin and Rui-qi Wang and Di Sun and Yi Yuan and Hongxiang Lou and Xian-Jun Qu},
  journal={Cancer letters},
  year={2013},
  volume={328 1},
  pages={
          104-13
        }
}

Figures and Tables from this paper

1118‐20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β‐catenin pathway and receptor tyrosine kinases
TLDR
The inhibitory effect on the growth of hepatocellular carcinoma cell line (HepG2) and suppression on angiogenesis of 1118‐20, a newly synthesized indazole diarylurea compound are evaluated.
Des-Gamma-Carboxy Prothrombin (DCP) Antagonizes the Effects of Gefitinib on Human Hepatocellular Carcinoma Cells
TLDR
DCP antagonized gefitinib-induced HCC cell growth inhibition by counteracting apoptosis and up-regulating the EGFR pathway and might thus lead to low response rates or possibly no response to gefithinib in patients with HCC.
HZ‐6d targeted HERC5 to regulate p53 ISGylation in human hepatocellular carcinoma
Synthesis of riccardin D derivatives as potent antimicrobial agents.
Cytotoxic Activity of Riccardin and Perrottetin Derivatives from the Liverwort Lunularia cruciata.
TLDR
Seven new bisbibenzyls (1-7) were isolated from the methanol extract of the liverwort Lunularia cruciata along with one previously known bibenzym, and exhibited cytotoxic activity against the A549 lung cancer cell line with IC50 values of 5.0, 5.5, and 2.5 μM.
...
1
2
...

References

SHOWING 1-10 OF 50 REFERENCES
Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II
TLDR
It is demonstrated that riccardin D is a novel DNA topo II inhibitor which can induce apoptosis of human leukemia cells and that it has therapeutic potential for both regular and MDR strains of leukemia cells.
Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents.
...
1
2
3
4
5
...